Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ

NCT06761846 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Esophagogastric Junction Adenocarcinoma

Interventions

BIOLOGICAL: Sintilimab plus Chemotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences